# Vytrus Biotech, S.A. (VYT.MC): MoatMap facts

As of 23 Oct 2026. Research data, not investment advice.

As of 23 Oct 2026, MoatMap's StockRank for Vytrus Biotech, S.A. (VYT.MC) is 66/100, ranked against 24,000+ stocks in 35 markets (Quality 86, Value 19, Momentum 55, each scored against its sector).

- StockRank: 66/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 86, Value 19, Momentum 55: each a 0-100 percentile within Healthcare.
- Position: #9,222 overall, #915 in Healthcare.
- Listing: Spain, MCE; Healthcare / Biotechnology.
- Last close: 15 EUR on 22 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/VYT.MC
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker
